image Follow Us:

Respiratio 2018; 8 (1-2): 14-19

 

KLINIČKE KARAKTERISTIKE PACIJENATA SA OPSTRUKTIVNOM APNEJOM U SPAVANJU

 

CLINICAL CHARACTERISTICS OF OBSTRUCTIVE SLEEP APNEA PATIENTS 

 

Sanja Glišić¹, Krsto Jandrić², Jelena Bogdanić¹, Igor Dumanović¹, Jelena Pijetlović¹, Mladen Bursać¹, Spomenka Paurević-Čutura, Draženko Vuković¹, Jasminka Aličehajić¹, Zorana Čović¹, Nataša Vajić¹, Ognjen Marinković¹

 

¹Zdravstveno turistički centar ‘’Banja Vručica’’, Teslić, Republika Srpska ,Bosna i Hercegovina

²Klinika za plućne bolesti, Klinički centar Banja Luka, Banja Luka, Republika Srpska, Bosna i Hercegovina

 

Original research

Naučni članak

doi: 10.26601/rsp.aprs.18.3

 

Sažetak: Opstruktivna apneja u spavanju je često oboljenje koje se u oko 85% pacijenata ne dijagnostikuje. Karakteriše se ponavljanim prekidima disanja u spavanju koji su uzrokovani potpunim ili djelimičnim kolapsom gornjih disajnih puteva, što izaziva pad saturacije kiseonika u krvi i posljedično isprekidan, neokrepljujući san.

U našem istraživanju smo ispitali kliničke karakteristike 33 pacijenta koji su uradili polisomnografski pregled u Specijalnoj bolnici za kardiovaskularnu rehabilitaciju „Hercegovina“ u ZTC Banja Vrućica u periodu od 01.01.2017. do 31.12.2017. godine.

 

Cilj našeg istraživanja je utvrditi učestalost riziko faktora za opstruktivnu apneju u spavanju kod naših ispitanika  i utvrditi učestalost i vrstu komorbiditeta. 

U našoj grupi ispitanika postojala je blaga predominacija muškog pola (57,5% ispitanika), prosječna starost 61 godina (SD 13,03). Najveći broj oboljelih (70%) je u starosnoj grupi 60 i više godina. BMI veći od 30 je imalo 70% ispitanika. Obim vrata veći od 40 cm je imalo 70% ispitanika. U grupi ispitanika sa visokim rizikom za apneju u spavanju (STOP BANG 5-8 bodova) je bilo 88,8% ispitanika. Jedan ili više komorbiditeta je imalo 75% ispitanika, od čega je najčešća bila hipertenzija, bolest koronarnih krvnih sudova, HOBP, šećerna bolest i različite aritmije. 

 

Ključne riječi: apneja u spavanju, riziko faktori, komorbiditeti

 

 

 

Full Article (PDF)

REFERENCES

1. Punjabi NM. The Epidemiology of Adult Obstructive Sleep Apnea. Proc Am Thorac Soc 2008;5:136-143.

[CrossRef]  

PMid:18250205 PMCid:PMC2645248

 

2. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrom in middle-aged men and women. Sleep 1997;20:705-706.

[CrossRef]    

PMid:9406321

 

3. Kapur V, Strohl KP, Redline S, Iber C, O'Connor G, Nieto J. Underdiagnosis of sleep apnea syndrome in US communities. Sleep Breath 2002;6:49-54.

[CrossRef]   

PMid:12075479

 

4. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurence of sleep-disorded breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.

[CrossRef]   

PMid:8464434

 

5. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, Kales A. Prevalence of sleep-disorded breathing in women: effects of gender. Am J Respir Crit Care Med 2001;163:608-613.

[CrossRef]   

PMid:11254512

 

6. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30-70 yr. Am J Respir Crit Care Med 2001:163:685-689.

[CrossRef] 

PMid:11254524

 

7. Redline S, Kump K, Tishler PV, Browner I, Ferrete V. Gender differences in sleep disorded breathing in a community-based sample. Am J Respir Crit Care Med 1994;149:722-726.

[CrossRef]   

PMid:8118642

 

8. Tishler PV, Larjin EK, Schluchter MD, Redline S. Incidence of sleep-disorded breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disorded breathing. JAMA 2003;289:2230-2237.

[CrossRef]   

PMid:12734134

 

9. Jordan AS, McEvoy RD. Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms. Sleep Med Rev 2003;7:377-389.

[CrossRef]   

 

10. Jordan AS, McEvoy RD, Edwards JK, Schory K, Yang CK, Catcheside PG et al. The influence of gender and upper airway resistance on the ventilatory response to arousal in obstructive sleep apnoea in humans. J Physiol 2004;558:993-1004.

[CrossRef]   

PMid:15218069 PMCid:PMC1665031

 

11. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-148.

[CrossRef]   

PMid:9445292

 

12. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disorded breathing. JAMA 2000;284:3015-3021.

[CrossRef]  

PMid:11122588

 

13. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disorded breathing and hypertension. N Engl J Med 2000;342:1378-1384.

[CrossRef]   

PMid:10805822

 

14. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long term follow-upp. Eur Respir J 2006;28:596-602.

[CrossRef]   

PMid:16641120

 

15. Punjabi NM, Polotsky VY. Disorders of glucosae metabolism in sleep apnea. J Appl Physiol 2005;99:1998-2007.

[CrossRef]   

PMid:16227461

 

16. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053.

[CrossRef]   

 

 

17. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177(9):1006-1014.

[CrossRef]   

PMid:23589584 PMCid:PMC3639722

 

18. Nagappa M, Liao P, Wong J, Auckley D, Ramachandran SK, Memtsoudis S et al. Validation of the STOP-Bang Questionnaire as a screening tool for obstructive sleep apnea among different populations: A systematic review and meta-analysis. PloS ONE 2015;10(12):e0143697. doi:10.1371/journal.pone.0143697.

[CrossRef]   

 

 

19. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de paula LKG, Amaro ACS et al. Obstructive sleep apnea: The most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011;58:811-817.

[CrossRef]   

PMid:21968750

 

20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. for the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, National Heart, Lung and Blood Institute; national High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.

[CrossRef]  

PMid:14656957

 

21. Sjostrom C, Lindberg E, Elmasry A, Hagg A, Svardsudd K, Janson C. Prevalence of sleep apnea and snoring in hypertensive men: a population based study. Thorax 2002;57:602-607.

[CrossRef]  

PMid:12096203 PMCid:PMC1746371

 

22. Drager LF, Genta PR, Pedrosa RP, Nerbass FB, Gonzaga CC, Krieger EM, Lorenzi-Filho G. Characteristics and predictors of obstructive sleep apnea in patientes with systemic hypertension. Am J Cardiol 2010; 105:1135-1139.

[CrossRef]   

PMid:20381666

 

23. Goncalves SC, Martinez D, Gus M, de Abreu-Silva EO, Bertoluci C, Dutra I et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007;132:1858-1862.

[CrossRef]   

PMid:18079220

 

24. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001;19:2271-2277.

[CrossRef]  

PMid:11725173

 

25. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest 1996; 109:659-63.

[CrossRef]   

PMid:8617073

 

26. Sorajja D, Gami AS, Somers VK, Berenbeck TR, Garcia-Touchard A, Lopez-Jimwnwz F. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 2008;133:927-33.

[CrossRef]   

PMid:18263678 PMCid:PMC2831406

 

27. McNicholas WT, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.

[CrossRef]  

PMid:17197482

 

28. Schafer H, Koehler U, Ewig S, Hasper E, Tasci S, Luderitz B. Obstructive sleep apnoea as a risk marker in coronary artery disease. Cardiology 1999;92:79-84.

[CrossRef]   

PMid:10702648

 

29. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF et al. Prospective study of obstructive sleep apnoea and incident coronary heart disease and heart failure:The Sleep Heart Health Study. Circulation 2010;122:352-60.

[CrossRef]   

PMid:20625114 PMCid:PMC3117288

 

30. Newman AB, Nieto FJ, Guidey U, Lind BK, Redline S, Pickering TG et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: The Sleep Heart Health Study. Am J Epidemiol 2001,154:50-9.

[CrossRef]   

PMid:11434366

 

31. Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995;151(1):82-86.

[CrossRef]  

PMid:7812577

 

32. Lopez-Acevedo MN, Torres-palacios A, Elena Ocasio-Tascon M, Campos-Santiago z, Rodriguez-Cintron W. Overlap syndrome: an indication for sleep studies?: a pilot study. Sleep Breath 2009;13(4):409-413.

[CrossRef]   

PMid:19479291

 

33. Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:279-289.

[CrossRef]  

PMid:8756795

 

34. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with essential hypertension. Annals of Internal Medicine. 1985;103(2):190–195. doi: 10.7326/0003-4819-103-2-190.

[CrossRef]  

 

 

35. Sanner B, Sturm A, Konermann M Coronary heart disease in patients with obstructive sleep apnea. Dtsch Med Wochenschr. 1996 Jul 26;121(30):931-5.

[CrossRef]   

PMid:8765700

 

Sanja Glišić

Cetinjska bb

74270 Teslić

Mobtel: 065 598 171 

E mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Travel Turne Tranzito